Cargando…

Clinical Tools for Peripheral Neuropathy to Exclude Cardiovascular Autonomic Neuropathy in Type 2 Diabetes Mellitus

INTRODUCTION: Assessment for cardiovascular autonomic neuropathy (CAN) remains difficult in everyday clinical practice. We sought to examine the diagnostic utility of various simple tools for diabetic peripheral neuropathy (DPN) in the detection of CAN in type 2 diabetes mellitus. METHODS: We examin...

Descripción completa

Detalles Bibliográficos
Autores principales: Pafili, Kalliopi, Trypsianis, Grigorios, Papazoglou, Dimitrios, Maltezos, Efstratios, Papanas, Nikolaos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7136368/
https://www.ncbi.nlm.nih.gov/pubmed/32172390
http://dx.doi.org/10.1007/s13300-020-00795-0
_version_ 1783518232877989888
author Pafili, Kalliopi
Trypsianis, Grigorios
Papazoglou, Dimitrios
Maltezos, Efstratios
Papanas, Nikolaos
author_facet Pafili, Kalliopi
Trypsianis, Grigorios
Papazoglou, Dimitrios
Maltezos, Efstratios
Papanas, Nikolaos
author_sort Pafili, Kalliopi
collection PubMed
description INTRODUCTION: Assessment for cardiovascular autonomic neuropathy (CAN) remains difficult in everyday clinical practice. We sought to examine the diagnostic utility of various simple tools for diabetic peripheral neuropathy (DPN) in the detection of CAN in type 2 diabetes mellitus. METHODS: We examined 153 type 2 diabetes mellitus subjects by various DPN tools (vibration perception threshold, 10 g Semmes-Weinstein monofilament, Ipswich touch test, NC-stat(®)/DPNCheck, neuropathy disability score) for the detection of CAN. CAN was diagnosed by the standardised cardiovascular autonomic reflex function tests. RESULTS: For the diagnosis of CAN, assessment of small nerve fibre function (pinprick sensation, temperature perception) yielded a very high negative predictive value (97%), with high sensitivity (89%) and moderate specificity (73%). The vibration perception threshold was second in diagnostic utility (91% negative predictive value, 62% sensitivity and 75% specificity). CONCLUSIONS: Based on their high negative predictive value, simple tools for DPN may prove useful to exclude CAN in type 2 diabetes mellitus. These encouraging results merit further evaluation to enable wider screening for CAN.
format Online
Article
Text
id pubmed-7136368
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer Healthcare
record_format MEDLINE/PubMed
spelling pubmed-71363682020-04-09 Clinical Tools for Peripheral Neuropathy to Exclude Cardiovascular Autonomic Neuropathy in Type 2 Diabetes Mellitus Pafili, Kalliopi Trypsianis, Grigorios Papazoglou, Dimitrios Maltezos, Efstratios Papanas, Nikolaos Diabetes Ther Original Research INTRODUCTION: Assessment for cardiovascular autonomic neuropathy (CAN) remains difficult in everyday clinical practice. We sought to examine the diagnostic utility of various simple tools for diabetic peripheral neuropathy (DPN) in the detection of CAN in type 2 diabetes mellitus. METHODS: We examined 153 type 2 diabetes mellitus subjects by various DPN tools (vibration perception threshold, 10 g Semmes-Weinstein monofilament, Ipswich touch test, NC-stat(®)/DPNCheck, neuropathy disability score) for the detection of CAN. CAN was diagnosed by the standardised cardiovascular autonomic reflex function tests. RESULTS: For the diagnosis of CAN, assessment of small nerve fibre function (pinprick sensation, temperature perception) yielded a very high negative predictive value (97%), with high sensitivity (89%) and moderate specificity (73%). The vibration perception threshold was second in diagnostic utility (91% negative predictive value, 62% sensitivity and 75% specificity). CONCLUSIONS: Based on their high negative predictive value, simple tools for DPN may prove useful to exclude CAN in type 2 diabetes mellitus. These encouraging results merit further evaluation to enable wider screening for CAN. Springer Healthcare 2020-03-14 2020-04 /pmc/articles/PMC7136368/ /pubmed/32172390 http://dx.doi.org/10.1007/s13300-020-00795-0 Text en © The Author(s) 2020 https://creativecommons.org/licenses/by-nc/4.0/This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Original Research
Pafili, Kalliopi
Trypsianis, Grigorios
Papazoglou, Dimitrios
Maltezos, Efstratios
Papanas, Nikolaos
Clinical Tools for Peripheral Neuropathy to Exclude Cardiovascular Autonomic Neuropathy in Type 2 Diabetes Mellitus
title Clinical Tools for Peripheral Neuropathy to Exclude Cardiovascular Autonomic Neuropathy in Type 2 Diabetes Mellitus
title_full Clinical Tools for Peripheral Neuropathy to Exclude Cardiovascular Autonomic Neuropathy in Type 2 Diabetes Mellitus
title_fullStr Clinical Tools for Peripheral Neuropathy to Exclude Cardiovascular Autonomic Neuropathy in Type 2 Diabetes Mellitus
title_full_unstemmed Clinical Tools for Peripheral Neuropathy to Exclude Cardiovascular Autonomic Neuropathy in Type 2 Diabetes Mellitus
title_short Clinical Tools for Peripheral Neuropathy to Exclude Cardiovascular Autonomic Neuropathy in Type 2 Diabetes Mellitus
title_sort clinical tools for peripheral neuropathy to exclude cardiovascular autonomic neuropathy in type 2 diabetes mellitus
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7136368/
https://www.ncbi.nlm.nih.gov/pubmed/32172390
http://dx.doi.org/10.1007/s13300-020-00795-0
work_keys_str_mv AT pafilikalliopi clinicaltoolsforperipheralneuropathytoexcludecardiovascularautonomicneuropathyintype2diabetesmellitus
AT trypsianisgrigorios clinicaltoolsforperipheralneuropathytoexcludecardiovascularautonomicneuropathyintype2diabetesmellitus
AT papazogloudimitrios clinicaltoolsforperipheralneuropathytoexcludecardiovascularautonomicneuropathyintype2diabetesmellitus
AT maltezosefstratios clinicaltoolsforperipheralneuropathytoexcludecardiovascularautonomicneuropathyintype2diabetesmellitus
AT papanasnikolaos clinicaltoolsforperipheralneuropathytoexcludecardiovascularautonomicneuropathyintype2diabetesmellitus